Advances in drug therapy of gastroesophageal reflux disease

Cover of: Advances in drug therapy of gastroesophageal reflux disease |

Published by Karger in Basel, New York .

Written in English

Read online


  • Gastroesophageal reflux -- Chemotheraphy.,
  • Gastroesophageal Reflux -- drug therapy.

Edition Notes

Includes bibliographical references and index.

Book details

Statementvolume editor, C. Scarpignato.
SeriesFrontiers of gastrointestinal research ;, vol. 20
ContributionsScarpignato, C.
LC ClassificationsRC815.7 .A38 1992
The Physical Object
Paginationp. cm.
ID Numbers
Open LibraryOL1555192M
ISBN 103805553609
LC Control Number91035369

Download Advances in drug therapy of gastroesophageal reflux disease

Get this from a library. Advances in drug therapy of gastroesophageal reflux disease. [C Scarpignato;]. This is a PDF-only article. The first page of the PDF of this article appears : J F Mackenzie. Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition in which stomach contents rise up into the esophagus, resulting in either symptoms or complications.

Symptoms include the taste of acid in the back of the mouth, heartburn, bad breath, chest pain, regurgitation, breathing problems, and wearing away of the cations: Esophagitis, esophageal. Furthermore, recent advances in prokinetics have enabled long-term control of lesions and symptoms when used in combination with PPI or P-CAB.

This may include herbal medicine. On the other hand, the development of a method for inhibiting the gastroesophageal reflux mechanism endoscopically or surgically, which is not drug therapy, is also.

Gastroesophageal reflux disease (GERD) is a chronic, relapsing disease with symptoms that have negative effects on daily life. Two treatment options are long-term medication or surgery. Gastroesophageal reflux, when excessive, causes a variety of injuries to the esophagus and adjacent organs: only local injuries to esophagus (­gastroesophageal reflux disease—GERD), and.

Introduction. Evidence-based guidelines supporting proton pump inhibitor (PPI) use as the superior option for antisecretory therapy (AST) for treatment of nonerosive gastroesophageal reflux disease (GERD), erosive esophagitis, dyspepsia and peptic ulcer disease have guided clinicians in the treatment of these conditions since their inception in the s, while Cited by: In contrast, gastroesophageal reflux disease (GERD) is globally defined as troublesome symptoms or complications associated with GER.

1 The symptoms of GERD can be either esophageal or extraesophageal and can be further characterized by findings of mucosal injury on upper endoscopy.

Gastroesophageal reflux (GER), defined as the passage of gastric contents into the esophagus, is a normal physiologic process occurring several times per day in healthy infants, children, and adults.

The majority of GER episodes occur in the postprandial period, last in Author: Paolo Quitadamo, Annamaria Staiano. Introduction. Laryngopharyngeal reflux (LPR) is defined as the reflux of gastric content into the larynx and pharynx [Vakil et al.

].According to the Montreal Consensus Conference, the manifestations of gastroesophageal reflux disease (GERD) have been classified into either esophageal or extraesophageal syndromes and, among the latter ones, the existence of an Cited by: Book reviewed in this article: β‐Adrenoceptors: Molecular Biology, Biochemistry and Pharmacology Ruffolo RR Jr., Editor.

β‐Adrenoceptors: Molecular Biology, Biochemistry and Pharmacology Ruffolo RR Jr., Editor. Advances in Drug Therapy of Gastroesophageal Reflux Disease Scarpignato C, Editor. Immunological and Pharmacological Aspects of Atopic and. Heading RC, Eaves NR () Aims of treatment in gastroesophageal reflux disease.

In: Scarpignato C (ed) Advances in drug therapy of gastroesophageal reflux disease. Frontiers of gastrointestinal research, vol Karger, Basel, pp 1–10 Google ScholarAuthor: J. Galmiche, S. Bruley des Varannes, C. Scarpignato.

Advances in Health and Disease. Volume 1 quantity. Add to cart. ISBN: while Chapter Two focuses on peri, postoperative and late complications. Chapter Three covers Gastroesophageal reflux disease (GERD), a disease characterized by abnormal reflux of gastric content and can be non-erosive or erosive, and the efficacy of a dietary compound.

Applies to: Gastroesophageal Reflux Disease Methylxanthines increase gastric acidity and may also relax lower esophageal sphincter, which can lead to gastric reflux into the esophagus. Therapy with products containing methylxanthines should be administered cautiously in patients with significant gastroesophageal reflux/ Title:Mechanisms of Esophageal Protection, Gastroprotection and Ulcer Healing by ations for the Therapeutic use of Melatonin in Gastroesophageal Reflux Disease (GERD) and Peptic Ulcer Disease.

VOLUME: 20 ISSUE: 30 Author(s):Iwona Brzozowska, Malgorzata Strzalka, Danuta Drozdowicz, Stanislaw J. Konturek and Tomasz Brzozowski. Other common obesity-related conditions include hypertension, heart disease, cancer, osteoarthritis of weight bearing joints, sleep apnea, respiratory problems, gastroesophageal reflux disease, depression, infertility, and urinary stress incontinence.

Obesity treatment may start with counseling on diet, exercise, and lifestyle : John Verhovshek. Medical therapy for gastroesophageal reflux disease (GERD) may be approached in two ways: directly applied to correct the underlying mechanisms involved in disease pathogenesis or alternatively applied to symptom severity in a “step-up” or “step-down” : Charles Muller, Natalie Tapaskar, Robert T.

Kavitt. Download PDF: Sorry, we are unable to provide the full text but you may find it at the following location(s): g (external link)Author: J F Mackenzie. Gastroesophageal reflux disease (GERD) has become increasingly common amongst Western cultures.

This chronic disease is now estimated to affect up to % of North America and % of Europe. 1 With 1 out of every 4 people suffering from this condition, it is not surprising that direct and indirect healthcare costs associated with GERD in the United States has reached.

Topics as the risks associated with GERD, lifestyle modification in GERD and the role of H2RA and proton pump inhibitor therapy in treating reflux disease are also explored. Written by authorities in the field, Diagnosis and Treatment of Gastroesophageal Reflux Disease is a concise yet comprehensive resource that is useful for primary care Brand: Springer International Publishing.

The life expectancy and quality of life of infants with congenital heart disease have increased in the last 30 years with significant advances in technological facilities, treatment methods, and surgeries.

GER is a condition that can be seen in infants with CHD, which needs to be well followed up and to be differentiated between physiological and nonphysiological : Mehmet Semih Demirtaş.

Gastroesophageal reflux disease refers to a clinical syndrome produced by the passage of gastric contents into the esophagus. The syndrome is usually manifested by the symptoms of heartburn, and may lead to the sequelae of esophagitis, stricture, or peptic ulcer of the by: 9. In: Scarpignato C (ed) Advances in Drug Therapy of Gastroesophageal Reflux Disease.

Basel: Karger, ; Smith JL, Opekun AR, Larkai E et al. Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology Parakrama T. Chandrasoma, Tom R. DeMeester, in GERD, The present treatment of patients with gastroesophageal reflux disease is highly successful in controlling pain, healing erosive esophagitis, preventing severe ulceration and stricture formation, and generally improving the quality of life for the vast majority of has been achieved as a result of.

Kang, J.H.-E & Kang, J.Y. Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations. Therapeutic Advances in Chronic Disease. / There have been several recent comprehensive reviews of gastroesophageal reflux (GER) and gastroesophageal reflux disease (GERD) in neonates that include evidence-based recommendations for treatment.

Nevertheless, it likely comes as no surprise to neonatologists to learn that this topic still engenders much debate.

For more than 60 years, Shackelford's Surgery of the Alimentary Tract has served as the cornerstone reference in this fast-moving field. With comprehensive coverage of all aspects of GI surgery, the 8th Edition, by Drs. Charles J.

Yeo, Steven R. DeMeester, David W. McFadden, Jeffrey B. Matthews, and James W. Fleshman, offers lavishly illustrated, authoritative Format: Book. ux and gastroesophageal reflux disease in the pediatric population. Methods: An international panel of 9 pediatric gastroenterologists and 2 epidemiologists were selected by both societies, which developed these guidelines based on the Delphi principle.

Statements were based on systematic literature searches using the best-available evidence from PubMed, Cumulative. Schindlbeck NE, Heinrich C, König A, Derndorfer A, Page F, Müller-Lissner SA.

Optimal thresholds, sensitivity, and specificity of long-term pH metry for the detection of gastroesophageal reflux disease. Gastroenterology ;   The book delineates the role of newly developed endoscopic therapies in GERD and outlines the best candidates for surgical fundoplication.

Topics as the risks associated with GERD, lifestyle modification in GERD and the role of H2RA and proton pump inhibitor therapy in treating reflux disease are also : Springer International Publishing. Enhanced PDF; Standard PDF ( KB) ; INTRODUCTION.

The primary goals of therapy for the majority of patients with gastro-oesophageal reflux disease (GERD) are symptom relief and prevention of relapse, while healing is also an important outcome for patients with erosive oesophagitis and/or complications.

1 It is well established, however, that the majority. Cameron and Cameron: Current Surgical Therapy, 13th edition Section 1. Esophagus. Esophageal Function Tests. Gastroesophageal Reflux Disease. New Approaches to Gastroesophageal Reflux Disease (LINX) 4.

The Management of Barrett's Esophagus. The Endoscopic Treatment of Barrett's Esophagus. The Management of 5/5(1). The primary indication for antireflux surgery in children with gastroesophageal reflux (GER) is failed medical therapy. Other indications include a history of recurrent aspiration events with or without pneumonia, reactive airway disease, apnea or near-miss sudden infant death syndrome (SIDS), refractory emesis, failure to thrive, esophagitis, esophageal stricture.

This improvement in survival, as well as in disease-associated morbidity and disability, is due to advances in diagnosis and early recognition of internal organ involvement, as well as successful management of selected complications such as pulmonary arterial hypertension, Raynaud phenomenon, gastroesophageal reflux disease, ischemic digital Author: John Varga, Fredrick M.

Wigley, Christopher P. Denton. Objectives To determine the incidence of gastroesophageal reflux in patients with subglottic stenosis (SGS) and to determine if upper esophageal reflux occurs in addition to lower esophageal reflux in these patients.

Design Esophageal pH probe studies were reviewed in patients diagnosed as having SGS. Setting A tertiary care pediatric medical by: Find support for a specific problem on the support section of our website. Please let us know what you think of our products and services.

Our dedicated information section provides allows you to learn more about MDPI. Head of the Otolaryngology Head and Neck Surgery Unit at Flinders Medical Centre, AdelaideAustralia. Several mechanisms such as persistent acid or weakly acidic reflux, oesophageal hypersensitivity or coexisting functional digestive disorders may influence the clinical response to PPI therapy.

35 Moreover, the reported course of symptoms after PPI therapy in patients with oesophageal eosinophilia has shown marked variation perhaps due to the Cited by: John Libbey Eurotext continues to publish the proceedings of the gastroenterology seminars taught by leading European specialists and organised by the European Association for Gastroenterology and Endoscopy (EAGE).

The aim of the book is to describe major clinical and therapeutic progress observed during gastrooesophageal reflux disease, inflammatory. Acid reflux (or GERD) and stomach cancer have similar symptoms. But, there are some key differences to consider before running down the rabbit hole of : Katherine Malmo.

Foregut Surgery: Achalasia, Gastroesophageal Reflux Disease and Obesity. Surgery of the Thoracic Spine: Principles and Techniques. Extraordinary technological advances in the last century have fundamentally altered the way we ask questions about biology, and undergraduate and graduate students must have the necessary tools to investigate.

Respiratory Manifestations of Gastroesophageal Reflux Disease in Pediatric Patients Nancy M. Bauman, MD, Anthony D. Sandler, MD, and Richard J. H. Smith, MD Annals of Otology, Rhinology & Laryngology 1, Cited by: As a result of these esophageal dysfunctions, SSc patients are at risk for associated complications that include gastroesophageal reflux disease .31 Gastroesophageal Reflux Disease in Infants and Children, Carlo Di Lorenzo and Yvan Vandenplas.

32 Surgical Treatment of Gastroesophageal Reflux Disease, Christy M. Dunst and Lee L. Swanstrom. 33 Obesity and Gastroesophageal Reflux Disease, Frank Friedenberg. Section V Malignant Disease.

34 Tumors of the Esophagus,

47944 views Friday, November 27, 2020